New therapeutic molecule yields new hope for Duchenne muscular dystrophy patients
Viral lessons from supercomputing
1 November 2021CBT intervention with yoga and education components improved pain management for patients on long-term opioids
1 November 2021New therapeutic molecule yields new hope for Duchenne muscular dystrophy patients
A research team led by Nicolas Dumont, a researcher at CHU Sainte-Justine and professor at the Université de Montréal, has discovered a new therapeutic molecule, Resolvin-D2. It has the potential to significantly improve the quality of life of patients with Duchenne muscular dystrophy (DMD) by stimulating muscle stem-cell activity.
